These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12218602)
21. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Ghani R; Manji MA; Ahmed N Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):855-61. PubMed ID: 12757239 [TBL] [Abstract][Full Text] [Related]
22. Pitfalls in newborn hemoglobinopathy screening: failure to detect beta(+)-thalassemia. Strickland DK; Ware RE; Kinney TR J Pediatr; 1995 Aug; 127(2):304-8. PubMed ID: 7636661 [TBL] [Abstract][Full Text] [Related]
23. Molecular identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from Brazil. Gonçalves MS; Fahel S; Figueiredo MS; Kimura EJ; Nechtman F; Stoming TA; Arruda VR; Saad ST; Costa FF Ann Hematol; 1995 Mar; 70(3):159-61. PubMed ID: 7536477 [TBL] [Abstract][Full Text] [Related]
24. Carrier screening for thalassemia and hemoglobinopathies in Canada. Langlois S; Ford JC; Chitayat D; ; J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079 [TBL] [Abstract][Full Text] [Related]
25. Regulation of the beta- and delta-hemoglobin genes. A family with hereditary persistent fetal hemoglobin and beta-thalassemia. Rothschild H; Bickers J; Marcus R Acta Haematol; 1976; 56(5):285-91. PubMed ID: 826085 [TBL] [Abstract][Full Text] [Related]
27. Frequency of hemoglobin E/β-thalassemia compound heterozygotes with low hemoglobin F phenotype among cases with a diagnosis of hemoglobin E homozygote, determined by high-performance liquid chromatography, in prenatal control program for β-thalassemia. Wong P; Srichaiya A; Suannum P; Charoenporn P; Jermnim S; Chan-In M; Tapprom A; Deoisares R Ann Hematol; 2017 Oct; 96(10):1763-1765. PubMed ID: 28803407 [No Abstract] [Full Text] [Related]
28. [A2' (B2) hemoglobin associated with beta thalassemia and hereditary persistence of fetal hemoglobin. Study in 3 Colombian families]. Echavarria A; Molina C; Zapata CI Sangre (Barc); 1973; 18(2):145-56. PubMed ID: 4753554 [No Abstract] [Full Text] [Related]
29. Molecular basis of deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia in Indian patients. Bhattacharya G; Banerjee D; Chandra S; Ghosh M; Chaudhuri U; Das M; Dasgupta UB Clin Chim Acta; 2008 Jun; 392(1-2):69-70. PubMed ID: 18343225 [No Abstract] [Full Text] [Related]
30. Wide range of F cell levels in healthy Thai adults: Influence of Swiss-type hereditary persistence of foetal haemoglobin & β-haemoglobinopathy. Tatu T Indian J Med Res; 2019 Aug; 150(2):161-166. PubMed ID: 31670271 [TBL] [Abstract][Full Text] [Related]
31. Hemoglobinopathies in pregnancy. Horger EO Clin Obstet Gynecol; 1974 Dec; 17(4):127-62. PubMed ID: 4615856 [No Abstract] [Full Text] [Related]
32. Non-anemic homozygous beta(o) thalassemia in an African-American family: association of high fetal hemoglobin levels with beta thalassemia alleles. Divoky V; Mrug M; Thornley-Brown D; Divoka M; Prchal JT Am J Hematol; 2001 Sep; 68(1):43-50. PubMed ID: 11559936 [TBL] [Abstract][Full Text] [Related]
33. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of isoelectric focusing and high performance liquid chromatography in neonatal cord blood screening for thalassemia and non-sickling hemoglobinopathies. Uaprasert N; Settapiboon R; Amornsiriwat S; Sarnthammakul P; Thanapat T; Rojnuckarin P; Sutcharitchan P Clin Chim Acta; 2014 Jan; 427():23-6. PubMed ID: 24095765 [TBL] [Abstract][Full Text] [Related]
35. Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern China. Lin M; Wen YF; Wu JR; Wang Q; Zheng L; Liu GR; Huang Y; Yang H; Lin F; Zhan XF; Lin CP; Yang HT; Weng QQ; Huang FT; Wang Y; Yao MQ; Chen HZ; Wu DH; Zeng JB; Zeng RX; Yang H; Li GC; Lu M; Zhu JJ; Xie LX; Wang JL; Yang LY PLoS One; 2013; 8(2):e55024. PubMed ID: 23383304 [TBL] [Abstract][Full Text] [Related]
37. Hemoglobin D Ibadan-beta zero thalassemia: detection by neonatal screening and confirmation by electrospray-ionization mass spectrometry. Lane PA; Witkowska HE; Falick AM; Houston ML; McKinna JD Am J Hematol; 1993 Nov; 44(3):158-61. PubMed ID: 8166888 [TBL] [Abstract][Full Text] [Related]
38. Haemoglobin E/beta-thalassaemia - an experience in the eastern Indian state of Orissa. Chhotray GP; Dash BP; Ranjit MR; Cohla RB; Mohanty D Acta Haematol; 2003; 109(4):214-6. PubMed ID: 12853699 [No Abstract] [Full Text] [Related]
39. Interaction of hemoglobin E with other abnormal hemoglobins. Edison ES; Shaji RV; Chandy M; Srivastava A Acta Haematol; 2011; 126(4):246-8. PubMed ID: 21986214 [No Abstract] [Full Text] [Related]